Tagged with Executive insight

pharma Luis Alemañy came to American Tools, Inc. as general manager in 2014 following a career largely focused on multinationals. He talks about the company’s new direction and their large international client base that has come about as a result of over 40 years of high-quality sheet metal manufacturing primarily for…

Pharma The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He also illustrates the underlying aspirations in targeting this market niche, while depicting the distinct set of hurdles faced from the…

Pharma The managing director of Galderma South Africa, Jenny Wright reveals the importance of the dermatology sector within the country’s healthcare system, as well as the role Galderma is playing in bringing dermatological solutions to the market and raising awareness of skin diseases. She also illustrates the factors that have truly…

Puerto Rico With a recent investment of $35 million in a new R&D site in Puerto Rico, Honeywell Aerospace continues to demonstrate its solid commitment to the country in its key role as part of the country’s aerospace sector. Site Leader Vicente Nazario outlines the growth of this division in Puerto Rico…

Pharma M&N Electronic Inc., also referred to as G.O.D Enterprises, provides hi-tech doors and material handling to the life sciences manufacturing industries of Puerto Rico and the Dominican Republic. The company’s president, Manuel De La Cruz, outlines M&N’s rapid growth since its inception in 2008 and future expansion opportunities. How did…

Pharma Pedro Tejada of Right Way Environmental introduces the environmental and life science markets in Puerto Rico and elaborates on the challenges that the company faces. What were the main reasons for the establishment of Right Way Environmental? I have worked in the environmental field since 1983. In 1995, my wife and…

pharma The managing director of Adcock Ingram’s prescription business, Ashley Pearce highlights the division’s strategic placement within the group’s overall activities, and how he plans on leveraging partnerships with various multinationals, expand into biosimilars and grow the generics business into a market leading position. Adcock Ingram has undergone several strategic changes…

pharma Pierre Banzet, President of Group Synerlab, one of the top ten French CMOs, discusses his group’s ambitious European expansion strategy, driven by their specialties in multi-dose, preservative-free eye drops, generics, medical devices and hospital markets, and uniqueness in terms of its culture of customer service. He also discusses his perspective…

pharma The general manager of Ferring South Africa, Mercia Van Zyl discusses the company’s ambitious plans for the future under the slogan ‘People come first’, the placement of fertility under the nation’s therapeutic priorities, and how the company is contributing to an overall better healthcare system in the country. Could you…

pharma CEO of Pantarhei since its inception in 2001, Herjan Coelingh Bennink outlines the company’s vision to develop new applications for existing compounds in the fields of women’s health and oncology with therapies with real medical advantages including a contraceptive pill which does not increase the risk of thrombosis and improved…

pharma The Netherlands provides a flourishing environment for biotech to grow. The vice president for European operations at Kite Pharma discusses how biotech start-ups can find their path to success and how Kite Pharma is looking at new innovative therapies for cancer treatment. Before joining T-Cell Factory, later acquired by Kite…

pharma IMS Health helps clients reach the top of the mountain by providing them with the necessary intelligence to take actionable steps. Manuel Voll, Senior Principal for Northern Europe shares his perspective about the Dutch healthcare and life sciences market, the challenges it poses and what companies can expect for the…